Artwork

Indhold leveret af The Radcliffe Cardiology Podcast. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af The Radcliffe Cardiology Podcast eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Ep 4: The EXCEL Trial: The Interventionalists’ Perspective

12:40
 
Del
 

Manage episode 318823677 series 2990303
Indhold leveret af The Radcliffe Cardiology Podcast. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af The Radcliffe Cardiology Podcast eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Did you know that left main stem disease is identified in 5% of diagnostic angiography cases? The EXCEL trial was a randomised clinical trial published in 2019 which studied left main stem disease of low or intermediate complexity. The trial came under controversy due to its definition of MI, leading to a loss in patient and public trust, and a deterioration in the relationship between the cardiothoracic and PCI communities. In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper: https://www.ecrjournal.com/articles/excel-trial-interventionalists-perspective?_ga=2.187238699.2063070761.1642409370-1520007507.1640163023 from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today. If you would like to learn more about the EXCEL Trial, view our special collection here: https://www.ecrjournal.com/special-collections/445/recent Episodes are released on the last Friday of each month. If you have any questions, please email managingeditor@ecrjournal.com.
  continue reading

44 episoder

Artwork
iconDel
 
Manage episode 318823677 series 2990303
Indhold leveret af The Radcliffe Cardiology Podcast. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af The Radcliffe Cardiology Podcast eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Did you know that left main stem disease is identified in 5% of diagnostic angiography cases? The EXCEL trial was a randomised clinical trial published in 2019 which studied left main stem disease of low or intermediate complexity. The trial came under controversy due to its definition of MI, leading to a loss in patient and public trust, and a deterioration in the relationship between the cardiothoracic and PCI communities. In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper: https://www.ecrjournal.com/articles/excel-trial-interventionalists-perspective?_ga=2.187238699.2063070761.1642409370-1520007507.1640163023 from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today. If you would like to learn more about the EXCEL Trial, view our special collection here: https://www.ecrjournal.com/special-collections/445/recent Episodes are released on the last Friday of each month. If you have any questions, please email managingeditor@ecrjournal.com.
  continue reading

44 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning